These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33301762)

  • 1. Lysosomal storage disorders: Novel and frequent pathogenic variants in a large cohort of Indian patients of Pompe, Fabry, Gaucher and Hurler disease.
    Thomas DC; Sharma S; Puri RD; Verma IC; Verma J
    Clin Biochem; 2021 Mar; 89():14-37. PubMed ID: 33301762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China.
    Chen X; Qiu W; Ye J; Han L; Gu X; Zhang H
    J Hum Genet; 2016 Apr; 61(4):345-9. PubMed ID: 26740238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosomal storage disorders. Diagnosis by ultrastructural examination of skin biopsy specimens.
    O'Brien JS; Bernett J; Veath ML; Paa D
    Arch Neurol; 1975 Sep; 32(9):592-9. PubMed ID: 809024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of 20 novel pathogenic variants in 60 unrelated Indian patients with mucopolysaccharidoses type I and type II.
    Uttarilli A; Ranganath P; Matta D; Md Nurul Jain J; Prasad K; Babu AS; Girisha KM; Verma IC; Phadke SR; Mandal K; Puri RD; Aggarwal S; Danda S; Sankar VH; Kapoor S; Bhat M; Gowrishankar K; Hasan AQ; Nair M; Nampoothiri S; Dalal A
    Clin Genet; 2016 Dec; 90(6):496-508. PubMed ID: 27146977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' perspectives on newborn screening for later-onset lysosomal storage diseases.
    Lisi EC; Gillespie S; Laney D; Ali N
    Mol Genet Metab; 2016 Sep; 119(1-2):109-14. PubMed ID: 27591925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in Taiwan.
    Liao HC; Chiang CC; Niu DM; Wang CH; Kao SM; Tsai FJ; Huang YH; Liu HC; Huang CK; Gao HJ; Yang CF; Chan MJ; Lin WD; Chen YJ
    Clin Chim Acta; 2014 Apr; 431():80-6. PubMed ID: 24513544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.
    Lepe-Balsalobre E; Santotoribio JD; Nuñez-Vazquez R; García-Morillo S; Jiménez-Arriscado P; Hernández-Arévalo P; Delarosa-Rodríguez R; Guerrero JM; Macher HC
    Clin Chem Lab Med; 2020 Jun; 58(12):2017-2024. PubMed ID: 32589593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients' view on gene therapy development for lysosomal storage disorders: a qualitative study.
    Eskes ECB; Beishuizen CRL; Corazolla EM; van Middelaar T; Brands MMMG; Dekker H; van de Mheen E; Langeveld M; Hollak CEM; Sjouke B
    Orphanet J Rare Dis; 2022 Oct; 17(1):383. PubMed ID: 36271424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysosomal storage disorders identified in adult population from India: Experience of a tertiary genetic centre and review of literature.
    Sheth J; Nair A; Bhavsar R; Godbole K; Datar C; Nampoothiri S; Panigrahi I; Shah H; Bajaj S; Tayade N; Bhardwaj N; Sheth H
    JIMD Rep; 2024 Mar; 65(2):85-101. PubMed ID: 38444573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T).
    Ebrahim HY; Baker RJ; Mehta AB; Hughes DA
    J Inherit Metab Dis; 2012 Mar; 35(2):325-34. PubMed ID: 21972175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of Lyso GL-1 in Gaucher and Lyso GL-3 in Fabry patients from India: Diagnostic aids for these lysosomal storage disorders.
    Verma J; Roy P; Thomas DC; Dua Puri R; Verma IC
    Clin Chim Acta; 2021 Oct; 521():177-190. PubMed ID: 34280392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of patients with lysosomal storage disorders and peroxisomal disorders: A nationwide survey in Japan.
    Koto Y; Sakai N; Lee Y; Kakee N; Matsuda J; Tsuboi K; Shimozawa N; Okuyama T; Nakamura K; Narita A; Kobayashi H; Uehara R; Nakamura Y; Kato K; Eto Y
    Mol Genet Metab; 2021 Jul; 133(3):277-288. PubMed ID: 34090759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease.
    Lukas J; Knospe AM; Seemann S; Citro V; Cubellis MV; Rolfs A
    J Vis Exp; 2017 Dec; (130):. PubMed ID: 29286471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segmental and total uniparental isodisomy (UPiD) as a disease mechanism in autosomal recessive lysosomal disorders: evidence from SNP arrays.
    Labrijn-Marks I; Somers-Bolman GM; In 't Groen SLM; Hoogeveen-Westerveld M; Kroos MA; Ala-Mello S; Amaral O; Miranda CS; Mavridou I; Michelakakis H; Naess K; Verheijen FW; Hoefsloot LH; Dijkhuizen T; Benjamins M; van den Hout HJM; van der Ploeg AT; Pijnappel WWMP; Saris JJ; Halley DJ
    Eur J Hum Genet; 2019 Jun; 27(6):919-927. PubMed ID: 30737479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature.
    Voorink-Moret M; Goorden SMI; van Kuilenburg ABP; Wijburg FA; Ghauharali-van der Vlugt JMM; Beers-Stet FS; Zoetekouw A; Kulik W; Hollak CEM; Vaz FM
    Mol Genet Metab; 2018 Feb; 123(2):76-84. PubMed ID: 29290526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating lysosomal storage disorders: What have we learnt?
    Lachmann RH
    J Inherit Metab Dis; 2020 Jan; 43(1):125-132. PubMed ID: 31140601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatable lysosomal storage diseases in the advent of disease-specific therapy.
    Peters H; Ellaway C; Nicholls K; Reardon K; Szer J
    Intern Med J; 2020 Nov; 50 Suppl 4():5-27. PubMed ID: 33210402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation identification of Fabry disease in families with other lysosomal storage disorders.
    Zampetti A; Fania L; Antuzzi D; Giurdanella F; Gnarra M; Bertola F; Lualdi S; Filocamo M; Morrone A; Feliciani C
    Clin Genet; 2013 Sep; 84(3):281-5. PubMed ID: 23210910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein structural features predict responsiveness to pharmacological chaperone treatment for three lysosomal storage disorders.
    Woodard J; Zheng W; Zhang Y
    PLoS Comput Biol; 2021 Sep; 17(9):e1009370. PubMed ID: 34529671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.